Cephalogics, LLC is working to develop and commercialize a novel noninvasive bedside neuroimaging system. The Cephalogics system will provide continuous measures and imaging from multiple cerebrovascular regions. A primary application of interest is neurocritical care where the technology would be used to guide care and optimize perfusion in injured brains. This technology will fill a significant gap that exists between current imaging technologies that require patient transport, expert interpretation, and are not continuous, and invasive neuromonitoring technologies that provide a single focal measure.
Cephalogics’ technology is the result of a partnership between Allied Minds and Dr. Joseph P. Culver at Washington University in St. Louis. Dr. Culver is an Assistant Professor in the Department of Radiology and a diffuse optical tomography expert.
Cephalogics neuroimaging system will display brain status measures and imaging from multiple cerebrovascular regions using a wearable brain cap. The core technology is based on diffuse optical tomography (DOT) and utilizes large, high-density, diffuse optical arrays to generate patient specific imaging. Proprietary signal processing algorithms will interpret and display data in real-time using this dense spatial sampling technique.
With unique capabilities as a neuroimaging method, DOT significantly expands upon other more established brain monitoring modalities. Initial human testing has yielded highly encouraging results and proved the feasibility of the technology.
We aim to commercialize the technology with an initial focus on patients suffering from ischemic stroke, hemorrhagic stroke, and traumatic brain injury in neurocritical care units and emergency departments. Additional markets of interest include surgery, interventional neuroradiology, and neonatology.